A/Prof Laurence Albiges and Dr Monty Pal discuss the changing landscape and biomarkers in metastatic renal cell carcinoma with A/Prof Andrew Weickhardt.
Prof Chris Sweeney discusses intermittent versus continuous ADT in metastatic hormone sensitive prostate cancer. Can you balance survival and quality of life?